Patients with active cancer should discuss BPC-157 with their oncologist, as its angiogenic and growth factor properties could theoretically be contraindicated in the setting of active malignancy
Learn more The potential of GLP-1 receptor agonists is immense, and new insights, applications, and risks are emerging all the time
Studies have demonstrated that transitioning between GLP-1 receptor agonists is generally well-tolerated when conducted appropriately, with patients able to maintain therapeutic benefits throughout the transition process
CrossRef The Effects of a Single Developmentally Entrained Pulse of Testosterone in Female Neonatal Mice on Reproductive and Metabolic Functions in Adult Life Hyeran Jang, Shalender Bhasin, Tyler Guarneri, Carlo Serra, Mary Schneider, Mi-Jeong Lee, Wen Guo, Susan K